References
- Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc.5(4), 549–555 (2008).
- Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA294(10), 1255–1259 (2005).
- Mancini GB, Etminan M, Zhang B et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J. Am. Coll. Cardiol.47(12), 2554–2560 (2006).
- Soyseth V, Brekke PH, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur. Respir. J.29(2), 279–283 (2007).
- Mortensen EM, Copeland LA, Pugh MJ et al. Impact of statins and ACE-inhibitors on mortality after COPD exacerbations. Respir. Res.10, 45 (2009).
- Dobler CC, Wong KK, Marks GB. Associations between statins and COPD: a systematic review. BMC Pulm. Med.9, 32 (2009).